Reduced total antioxidant capacity predicts ischaemia-reperfusion injury after femorodistal bypass

被引:0
|
作者
Spark, JI
Chetter, IC
Gallavin, L
Kester, RC
Guillou, PJ
Scott, DJA
机构
[1] St James Univ Hosp, Dept Vasc & Endovasc Surg, Vasc Lab, Leeds LS9 7TF, W Yorkshire, England
[2] St James Univ Hosp, Professorial Surg Unit, Leeds LS9 7TF, W Yorkshire, England
关键词
D O I
暂无
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background Antioxidant defence systems are essential to protect the body from harmful free radicals released following ischaemia-reperfusion. The aim of this study was to examine the total antioxidant capacity (TAG) of patients with chronic critical leg ischaemia undergoing femorodistal bypass and to correlate this with lipid peroxidation, changes in capillary permeability and clinical outcome. Methods Twenty-five patients, 15 men and ten women of median age 71 (range 62-79) years, and 15 matched controls were studied. Blood was taken before operation and after reperfusion, with assays performed for malondialdehyde (a product of lipid peroxidation) and total antioxidant capacity. Changes in capillary permeability were measured by changes in the urinary albumin:creatinine ratio (ACR) following reperfusion of the ischaemic leg and expressed as a percentage increase from the preoperative value. Clinical outcome in terms of the systemic inflammatory response syndrome (SIRS) was recorded. Results Vascular patients who developed clinical evidence of a systemic inflammatory reaction following revascularization had a significantly reduced TAC compared with the controls (490 versus 860 mu mol/l; P < 0.01. Mann-Whitney U test). These patients also demonstrated an increase in lipid peroxidation (0.5 versus 0.25 mu mol/l, P < 0.05) and vascular permeability, as measured by the percentage increase in ACR (365 versus 130 per cent, P < 0.01). Conclusion Vascular patients with a lower TAC developed increased capillary permeability as a result of ischaemia-reperfusion, which progressed to SIRS. TAC may provide a test to identify 'at risk' patients. It may be possible to augment their defence with exogenous antioxidants.
引用
收藏
页码:221 / 225
页数:5
相关论文
共 50 条
  • [1] Renal ischaemia-reperfusion injury
    Weight, SC
    Bell, PRF
    Nicholson, ML
    BRITISH JOURNAL OF SURGERY, 1996, 83 (02) : 162 - 170
  • [2] Ischaemia-reperfusion injury to the intestine
    Kong, SE
    Blennerhassett, LR
    Heel, KA
    McCauley, RD
    Hall, JC
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY, 1998, 68 (08): : 554 - 561
  • [3] Mechanisms of ischaemia-reperfusion injury
    Jaeschke, H
    HEPATOLOGY 2000: SYMPOSIUM IN HONOR OF GUSTAV PAUMGARTNER, 2001, 117 : 259 - 269
  • [4] Pathophysiology of ischaemia-reperfusion injury
    Carden, DL
    Granger, DN
    JOURNAL OF PATHOLOGY, 2000, 190 (03): : 255 - 266
  • [5] Hepatic hypoperfusion after intestinal ischaemia-reperfusion injury
    Williams, SB
    Williams, SR
    Pierro, A
    BRITISH JOURNAL OF SURGERY, 2001, 88 : 20 - 20
  • [6] Protective antioxidant effects of carvedilol in a rat model of ischaemia-reperfusion injury
    Akbas, H
    Ozden, M
    Kanko, M
    Maral, H
    Bulbul, S
    Yavuz, S
    Ozker, E
    Berki, T
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2005, 33 (05) : 528 - 536
  • [7] Complement in ischaemia-reperfusion injury and transplantation
    Howard, Mark C.
    Nauser, Christopher L.
    Farrar, Conrad A.
    Sacks, Steven H.
    SEMINARS IN IMMUNOPATHOLOGY, 2021, 43 (06) : 789 - 797
  • [8] Hyperglycaemia and renal ischaemia-reperfusion injury
    Melin, J
    Hellberg, O
    Fellström, B
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2003, 18 (03) : 460 - 462
  • [9] Murine renal ischaemia-reperfusion injury
    Kennedy, Sean E.
    Erlich, Jonathan H.
    NEPHROLOGY, 2008, 13 (05) : 390 - 396
  • [10] Necroptosis in Hepatosteatotic Ischaemia-Reperfusion Injury
    Baidya, Raji
    Crawford, Darrell H. G.
    Gautheron, Jeremie
    Wang, Haolu
    Bridle, Kim R.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (16) : 1 - 29